UK markets close in 4 hours 25 minutes

Universe Pharmaceuticals INC (UPC)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
2.9230+0.2380 (+8.86%)
At close: 04:00PM EDT
2.8500 -0.07 (-2.50%)
After hours: 06:02PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/09/2023
30/09/2022
30/09/2021
30/09/2020
30/09/2019
Total revenue
32,309
32,309
40,143
47,982
30,704
-
Cost of revenue
21,994
21,994
18,252
22,656
16,610
-
Gross profit
10,315
10,315
21,891
25,326
14,094
-
Operating expenses
Research development
4,859
4,859
7,644
5,466
583.125
-
Selling general and administrative
9,001
9,001
20,836
6,043
2,795
-
Total operating expenses
14,281
14,281
28,911
11,966
3,744
-
Operating income or loss
-3,966
-3,966
-7,019
13,360
10,350
-
Interest expense
156.788
156.788
162.4
101.604
123.76
-
Total other income/expenses net
273.315
273.315
-802.302
420.117
-125.633
-
Income before tax
-3,850
-3,850
-7,984
13,678
10,100
-
Income tax expense
2,313
2,313
752.419
2,359
2,542
-
Income from continuing operations
-6,163
-6,163
-8,737
11,320
7,558
-
Net income
-6,163
-6,163
-8,737
11,320
7,558
-
Net income available to common shareholders
-6,163
-6,163
-8,737
11,320
7,558
-
Basic EPS
-3.08
-
-2.41
3.58
2.16
2.16
Diluted EPS
-3.08
-
-2.41
3.58
2.16
2.16
Basic average shares
3,625
-
3,625
3,163
3,500
3,500
Diluted average shares
3,625
-
3,625
3,163
3,500
3,500